Evidence map›Paper›PMID 30723150›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2019

The

Samuel H Becker, Jordan B Jastrab, Avantika Dhabaria, Catherine T Chaton, Jeffrey S Rush, Konstantin V Korotkov, Beatrix Ueberheide, K Heran Darwin

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.7field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 35 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Future Research Directions on Mycobacterium tuberculosis Proteins.Advances in experimental medicine and biology · 2026
    Review
  5. Review
  6. Article
  7. Article
  8. Identification of a depupylation regulator for an essential enzyme inProceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  9. Article
  10. Review
  11. Response of bacterial communities in saline-alkali soil to different pesticide stresses.Environmental science and pollution research international · 2022
    Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Control of Toxin-Antitoxin Systems by Proteases inFrontiers in molecular biosciences · 2021
    Review
  17. Article
  18. Review
  19. Microbiology spectrum · 2019
    Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Samuel H BeckerDepartment of Microbiology, New York University School of Medicine, New York, NY 10016.
Jordan B JastrabDepartment of Microbiology, New York University School of Medicine, New York, NY 10016.
Avantika DhabariaProteomics Laboratory, Division of Advanced Research Technologies, New York University School of Medicine, New York, NY 10016.
Catherine T ChatonDepartment of Molecular and Cellular Biochemistry, University of Kentucky, Lexington, KY 40536.
Jeffrey S RushDepartment of Molecular and Cellular Biochemistry, University of Kentucky, Lexington, KY 40536.
Konstantin V KorotkovDepartment of Molecular and Cellular Biochemistry, University of Kentucky, Lexington, KY 40536.ORCID 0000-0002-2182-6843
Beatrix UeberheideProteomics Laboratory, Division of Advanced Research Technologies, New York University School of Medicine, New York, NY 10016.
K Heran DarwinDepartment of Microbiology, New York University School of Medicine, New York, NY 10016; heran.darwin@med.nyu.edu.
New York University · USUniversity of Kentucky · US

Funding

INFECTIOUS DISEASES &BASIC MICROBIOLOGICAL MECHANISMST32AI007180 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI WEISER, JEFFREY NEAL · 1985 to 2022
$8.9M
PROTEASOME-DEPENDENT DEGRADATION IN MYCOBACTERIUM TUBERCULOSISR01AI088075 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Katerina Heran Darwin · 2011 to 2026
$6.5M
Virulence Regulation by the Mycobacterium Tuberculosis ProteasomeR01HL092774 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI DARWIN, KATERINA HERAN · 2007 to 2017
$4.0M
Targeting NAD biosynthesis in Mycobacterium tuberculosisR03AI117361 · NIAID · UNIVERSITY OF KENTUCKY · PI KOROTKOV, KONSTANTIN V · 2015 to 2016
$150k
Characterization of a novel cofactor of the M. tuberculosis proteasomeF30AI110067 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI JASTRAB, JORDAN B · 2014 to 2017
$111k
NHLBI NIH HHS R01 HL092774NIAID NIH HHS F30 AI110067NIAID NIH HHS R01 AI088075NIAID NIH HHS R03 AI117361NIAID NIH HHS T32 AI007180
6 · The paper itself

Abstract

The human pathogen

Indexed as

Ammonium CompoundsAntigens, BacterialBacterial Outer Membrane ProteinsBacterial ProteinsChaperonin 60ChaperoninsHeat-Shock ProteinsHumansMycobacterium tuberculosisNitrogenProteasome Endopeptidase ComplexProteolysisTuberculosisAmmonium CompoundsAntigens, BacterialBacterial Outer Membrane ProteinsBacterial ProteinsChaperonin 60ChaperoninsgroES protein, Mycobacterium tuberculosisHeat-Shock ProteinsNitrogenProteasome Endopeptidase ComplexchaperoninsMycobacteriumnitrateproteasometuberculosis

Identifiers

PMID30723150
PMCPMC6386731
OpenAlexW2952939729

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.